BridgeMD
New treatment option for CKD (Chronic Kidney Disease) Stage 5D
Official title ASPIrin in Reducing Events in Dialysis ( ASPIRED )
ClinicalTrials.gov ID: NCT04381143
What this study is testing
What is Aspirin 100 mg Oral Tablet?
Aspirin 100 mg Oral Tablet is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for ckd (chronic kidney disease) stage 5d.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- People with kidney failure requiring dialysis have a much higher risk of developing cardiovascular (CV) disease compared with the general population. A cardiac cause accounts for 58% of all deaths in patients with end stage kidney disease (ESKD).
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Incident or prevalent adults (≥18 years old) dialysis patients are included in the Dialysis Registry.
- Commenced on dialysis with the expectation of ongoing maintenance dialysis requirement.
- Willing and able to provide informed consent for this study.
You likely can't join if
- Requirement for any form of antiplatelet agent (aspirin, glycoprotein IIb/IIIa inhibitors etc), or oral anticoagulation (warfarin, NOACs), in the...
- Contraindication to aspirin, in the view of the treating physician.
- Dialysis requirement due to acute kidney injure with expectation of kidney function recovery.
- History of haemorrhagic stroke or intracranial bleed within 12 months of screening.
- Coagulopathy from any cause.
- Unable to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Fuzhou, Fujian, China
- Longyan, Fujian, China
- Lanzhou, Gansu, China
- Dongguan, Guangdong, China
- Donghai, Guangdong, China
- Foshan, Guangdong, China
- Guangzhou, Guangdong, China
- Guanzhou, Guangdong, China
- Heyuan, Guangdong, China
- Huizhou, Guangdong, China
- Jiangmen, Guangdong, China
- Jieyang, Guangdong, China
- Kaiping, Guangdong, China
- Lianjiang, Guangdong, China
- Lianping, Guangdong, China
- Licheng, Guangdong, China
- Maoming, Guangdong, China
- Meizhou, Guangdong, China
- Puning, Guangdong, China
- Qingyuan, Guangdong, China
+ 44 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fuzhou, Fujian, China; Longyan, Fujian, China; Lanzhou, Gansu, China; Dongguan, Guangdong, China; Donghai, Guangdong, China; Foshan, Guangdong, China and 58 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.